MicroRNAs in skin and wound healing

J Banerjee, YC Chan, CK Sen - Physiological genomics, 2011 - journals.physiology.org
MicroRNAs (miRNAs) are small endogenous RNA molecules∼ 22 nt in length. miRNAs are
capable of posttranscriptional gene regulation by binding to their target messenger RNAs …

Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review

E Sbidian, A Maza, H Montaudié… - Journal of the …, 2011 - Wiley Online Library
Background There is limited evidence regarding the efficacy and safety of retinoids in
different psoriasis subtypes. Objective To systematically review the available literature on:(i) …

Attributable risk estimate of severe psoriasis on major cardiovascular events

NN Mehta, YD Yu, R Pinnelas… - The American journal of …, 2011 - Elsevier
BACKGROUND: Recent studies suggest that psoriasis, particularly if severe, may be a risk
factor for major adverse cardiac events, such as myocardial infarction, stroke, and mortality …

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

TF Tsai, TS Wang, ST Hung, I Phiona, C Tsai… - Journal of …, 2011 - Elsevier
BACKGROUND: Recent findings in psoriasis research have shown that psoriasis is
frequently associated with systemic comorbidities. OBJECTIVES: This study aims to describe …

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography–computed …

NN Mehta, YD Yu, B Saboury, N Foroughi… - Archives of …, 2011 - jamanetwork.com
Objective To evaluate the feasibility of using [18F]-fluorodeoxyglucose positron emission
tomography–computed tomography (FDG-PET/CT) to detect and quantify systemic …

[HTML][HTML] Resolved psoriasis lesions retain expression of a subset of disease-related genes

M Suárez-Fariñas, J Fuentes-Duculan… - Journal of Investigative …, 2011 - Elsevier
Psoriasis is a complex inflammatory disease that usually heals without visible scarring.
Histological evaluation often suggests complete resolution, but reversal of genomic disease …

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies

K Reich, RG Langley, M Lebwohl… - British Journal of …, 2011 - academic.oup.com
Background Patients with psoriasis are believed to be at an increased risk of cardiovascular
(CV) morbidity, and the effect of biological agents on CV safety is not fully understood …

Psoriasis and hypertension severity: results from a case-control study

AW Armstrong, SW Lin, CJ Chambers, ME Sockolov… - PLoS …, 2011 - journals.plos.org
Background Epidemiologic studies have provided new insights into the association between
psoriasis and cardiovascular diseases. Previous population studies have examined …

[PDF][PDF] S3‐Leitlinie zur Therapie der Psoriasis vulgaris Update 2011

A Nast, WH Boehncke, U Mrowietz… - JDDG: Journal der …, 2011 - psoriasis-rheinruhr.de
1.1 Bedarfsanalyse/Probleme in der Versorgung der Patienten Die Psoriasis vulgaris stellt
eine häufige und fast immer chronisch verlaufende dermatologische Erkrankung dar. Die …

[HTML][HTML] Psoriasis and cardiovascular risk: strength in numbers, part II

JM Gelfand, NN Mehta, SM Langan - Journal of Investigative Dermatology, 2011 - Elsevier
The Psoralen plus Ultraviolet-A (PUVA) cohort study has been a tremendous success in
determining how a novel treatment (ie, PUVA) affects the long-term risk of keratinocyte …